FDA-Approved Heart Drug Dronedarone Shows Promise as Novel Lymphoma Treatment Through USP11 Enzyme Targeting
核心洞察
Researchers at VCU Massey Comprehensive Cancer Center (搜索) discovered that dronedarone, an FDA-approved heart medication, can effectively target lymphoma (搜索) cells by inhibiting the USP11 (搜索) enzyme through a novel non-catalytic approach.
The drug demonstrated potent activity against diffuse large B-cell lymphoma (搜索) cells in preclinical models while sparing normal cells, significantly reducing tumor growth and preventing metastatic spread without observable toxicity.
This breakthrough represents a potential drug repurposing opportunity that could accelerate clinical trials by leveraging existing safety data for dronedarone.
Researchers at VCU Massey Comprehensive Cancer Center (搜索) have identified a promising new therapeutic approach for lymphoma (搜索) treatment by repurposing dronedarone, an FDA-approved medication for irregular heartbeat. The team discovered that the cardiac drug can selectively target lymphoma cells through a novel mechanism involving the USP11 (搜索) enzyme, potentially transforming precision medicine approaches in cancer therapy.
The findings, published in Pharmacological Research, demonstrate how dronedarone—marketed under the research designation RBF4 (搜索)—effectively kills cancer cells and reduces tumor growth with minimal toxicity in preclinical models.
Novel Enzyme Targeting Strategy
The breakthrough centers on USP11 (搜索), an enzyme belonging to the deubiquitinase (DUB) family that regulates protein stability within cells. Traditional drug development efforts have focused on blocking the catalytic active sites of these enzymes, but this approach has faced significant challenges due to structural similarities among DUB family members, leading to off-target effects and poor drug-like properties.
"These findings redefine our understanding of the USP11 (搜索) enzyme and shed light on the anti-tumor effects of RBF4 (搜索)—an existing heart medication—illuminating a new therapeutic approach in lymphoid malignancies and beyond," said study senior author Ronald Gartenhaus, M.D., associate director for veterans health at Massey and director of the Richmond VA Cancer Center (搜索).
The VCU team adopted an innovative strategy by targeting USP11 (搜索)'s ubiquitin-like (UBL) domain, a non-catalytic scaffolding region that enables the enzyme to interact with protein partners. This approach exploited structural differences unique to USP11 that distinguish it from closely related family members like USP4 (搜索) and USP15 (搜索).
Computational Discovery Process
Glen E. Kellogg, Ph.D., a professor emeritus at the VCU School of Pharmacy (搜索), led the computational chemistry efforts that proved central to the discovery. Using structure-based virtual screening, his team analyzed over 10 million compounds to identify molecules capable of selectively binding USP11 (搜索)'s scaffolding domain, ultimately leading to the identification of RBF4 (搜索).
The computational approach successfully identified inhibitors that demonstrated potent activity against diffuse large B-cell lymphoma (搜索) cells while largely sparing normal cells, addressing a critical challenge in cancer therapy selectivity.
Preclinical Efficacy Results
In preclinical models of MYC (搜索)-driven lymphoma (搜索), RBF4 (搜索) significantly reduced tumor growth, prevented metastatic spread, and inhibited fluid accumulation, all without observable damage to surrounding tissue. These results are particularly significant given that diffuse large B-cell lymphoma (搜索) represents the most common and fast-growing type of non-Hodgkin lymphoma (搜索), accounting for approximately one in every three lymphomas according to the American Cancer Society.
The discovery that RBF4 (搜索) is chemically identical to dronedarone represents a serendipitous breakthrough that could accelerate the path to clinical trials by leveraging established safety data from the drug's cardiac applications.
Clinical Translation Potential
"The fact that this molecule has already been used without significant toxicities in patients was reassuring because now we know that it can already be used safely and effectively for certain patients in the clinical setting," said Gartenhaus, whose laboratory has been studying RNA translation and lymphoma (搜索) for decades.
The research builds on previous work by Kapadia and Gartenhaus, published in Nature Communications, which demonstrated USP11 (搜索)'s critical role in controlling protein production in lymphoma (搜索) cells, establishing it as an attractive therapeutic target.
Future Clinical Development
The researchers are collaborating with Victor Yazbeck, M.D., a hematologist-oncologist, to investigate RBF4 (搜索)'s efficacy for lymphoma (搜索) through clinical trials at Massey. If initial clinical trials demonstrate effectiveness, the drug could potentially target a wide range of other tumors, as USP11 (搜索) has been implicated in breast, cervical, colorectal, esophageal, liver, ovarian, and pancreatic cancers.
This drug repurposing approach represents a potentially faster and more cost-effective pathway to bringing new cancer treatments to patients, as it bypasses many of the early safety studies typically required for novel compounds.